Medtronic reports second quarter fiscal 2023 financial results

Earnings delivered despite slower market procedure volume and supply recovery; growth driven by tavr, pacing, u.s. core spine, and international diabetes dublin , nov. 22, 2022 /prnewswire/ -- medtronic plc (nyse:mdt) today announced financial results for its second quarter of fiscal year 2023, which ended october 28, 2022. key highlights revenue of $7.6 billion decreased 3% as reported and increased 2% organic gaap diluted eps of $0.32 decreased 67%; non-gaap diluted eps of $1.30 decreased 2% company updates guidance; expects organic revenue to accelerate in second half "we're taking decisive actions to improve the performance of the company.
MDT Ratings Summary
MDT Quant Ranking